Although BCL-XL and MCL-1 were not prognostic indicators in SCCHN, dual inhibition resulted in extensive apoptosis in all preclinical models including tumor explants, as well as a decreased tumor burden in zebrafish xenografts (Figs. 4 and 5). Here, MCL1 is linked to neoplasm.